ASX 200

Geopolitics and energy shortages underpin the investment thesis for the likes of lithium, nickel, rare earths and copper.

We reached out to Lucerne Investment Partners's founder and CEO, Anthony Murphy, to answer your questions on this burgeoning asset class.

The Match Out for Wednesday 1 November with James Gerrish of Market Matters.

Investing in what you are passionate about, or even what you consume everyday, can give you an edge. So, what do you know?

Get up to date on overnight market activity and the big events for the day.

For convenience, in this article “ETFs” refers collectively to all exchange tradeable funds available in the market, whether passively or actively managed, including...

Last week, we highlighted the record Australian gold price and our top three gold picks. On Monday, one received a takeover offer.

ASX AGM season is upon us - and the commentary is revealing.

The daily Match Out for Tuesday 31 October with James Gerrish of Market Matters

Investing in gold, iron ore and coal doesn't require an understanding of complex global futures markets.

It’s annual general meeting (AGM) season and our teams are furiously note-taking at dozens of company briefings where the opportunity to provide analysts with an...

There are signs the global economy is gradually slowing. Pendal’s Anthony Moran explains what that means for Aussie equities portfolios

The daily Match Out for Monday 30 October 2023 with James Gerrish of Market Matters

We know the issues, but how can you profit from the structural changes happening in markets right now?

In this interview, reader favourite Romano Sala Tenna shares a key risk that should be on your radar.

And only one of this year's stock picks is a "short".

Weekly Update | 27th October, 2023

In a world where macro news is nothing short of chaotic and confusing, it’s worth focusing on the micro for a change.

The Azure Minerals takeover by SQM looks to be perfect match in terms of prospect, capital, expertise and offtake. Why did I sell on market?

ResMed CEO Mick Farrel says weight loss drugs could be bringing more patients into the CPAP funnel.

Get up to date on overnight market activity and the big events for the day.

Spotlight swings to Patriot and Wildcat, plus Calidus’ new Bulletin gold deposit is being likened to Spartan’s rich Never Never find.

In today's episode, we'll attempt to break the internet with stocks that are sexier right now than the Kardashians.

The daily Match Out for Thursday 26 October 2023 with James Gerrish of Market Matters